Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.

Jung Woo ShinJoonho JeongSeok Won JungSeung Bum LeeBo Ryung ParkMin-Ju KimEun Ji ParkNeung-Hwa Park

Published in: Digestive diseases and sciences (2020)

After adjustment for adherence and MVR, ETV, and TDF did not differ in terms of the risk of HCC and death or transplantation in all patients and propensity score-matched cohorts.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
acute lymphoblastic leukemia
hepatitis b virus
peritoneal dialysis
risk factors
stem cells
type diabetes
patient reported outcomes